← Back to Clinical Trials
Recruiting NCT06845176

NCT06845176 Combining Motor Imagery and Tendon Vibration on the Effectiveness of Motor Imagery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06845176
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire de Saint Etienne
Condition Healthy Volunteer
Study Type INTERVENTIONAL
Enrollment 33 participants
Start Date 2026-03-27
Primary Completion 2027-03-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
Tendon vibration (TV)Kinesthetic motor imagery (kMI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 33 participants in total. It began in 2026-03-27 with a primary completion date of 2027-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Kinesthetic motor imagery (kMI) involves imagining the sensations of movement, activating brain regions similar to actual movement execution. It is widely used to maintain or restore motor functions, particularly in rehabilitation. Tendon vibration (TV), which stimulates proprioceptive receptors can also enhance corticospinal excitability and promote neuroplasticity. This project investigates the coupling of kMI and TV through three modalities: simultaneous application, TV application between kMI trials, or pre-application of TV to precondition the nervous system before kMI trials. The effectiveness and quality of kMI will be assessed by corticospinal excitability measurements using transcranial magnetic stimulation and EEG measures. Conducting this study in healthy participants will inform the development of optimized clinical interventions for immobilized or mobility-reduced patients.

Eligibility Criteria

Inclusion Criteria: * Men or women aged 18 to 50 years. * Affiliated with or beneficiaries of a social security system. * Provided written informed consent freely after being informed of the study's purpose, procedures, and potential risks. Exclusion Criteria: * History of pathology or surgery affecting upper limb motor function within 6 months prior to the study. * Chronic neurological, motor, or psychiatric disorders. * Use of neuroactive substances likely to alter corticospinal excitability (e.g., hypnotics, antiepileptics, psychotropics, muscle relaxants) during the study period. * Contraindications to transcranial magnetic stimulation * Simultaneous participation in another interventional study or participation in such a study within 30 days prior to this study.

Contact & Investigator

Central Contact

Léonard FEASSON, PhD

✉ leonard.feasson@univ-st-etienne.fr

📞 04 77 12 03 83

Principal Investigator

Léonard FEASSON, PhD

PRINCIPAL INVESTIGATOR

Centre Hospitalier Universiatire de SAINT-ETIENNE

Frequently Asked Questions

Who can join the NCT06845176 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Healthy Volunteer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06845176 currently recruiting?

Yes, NCT06845176 is actively recruiting participants. Contact the research team at leonard.feasson@univ-st-etienne.fr for enrollment information.

Where is the NCT06845176 trial being conducted?

This trial is being conducted at Saint-Etienne, France.

Who is sponsoring the NCT06845176 clinical trial?

NCT06845176 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Léonard FEASSON, PhD at Centre Hospitalier Universiatire de SAINT-ETIENNE. The trial plans to enroll 33 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology